Trial intelligence / Profile preview

Real-time Decision Support for PONV Prophylaxis

NCT02625181Completed

Sponsor
Vanderbilt University
Start
Jul 2016
Primary completion
Nov 2017
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Vanderbilt University. Primary endpoint: Adherence to PONV Guidelines. Started Jul 2016; status: completed.

Beyond the preview

Go deeper on NCT02625181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02625181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call